←back to thread

275 points swores | 5 comments | | HN request time: 0.335s | source
Show context
kazinator ◴[] No.40174260[source]
The cost of developing drugs is high because of all the drugs that fail, after requiring lots of money to develop. You can't just look at the successful drug and say that's the cost. There are drugs that don't get to the trial stage, so also you can't just look at trials, even if you include failed ones.

The researchers cited in this article seem to be promulgating the fallacy that we need only look at the cost of a successful drug trial, and that's the cost. The drugs magically appeared out of nowhere, for free, and equally magically, they are working drugs, so we already know our trial will succeed. It's just a charade we have to go pay for to get the government's rubber stamp, and then it's all good!

replies(3): >>40175091 #>>40176436 #>>40182039 #
1. redserk ◴[] No.40175091[source]
What about the public funding that led to research and presumably went towards some of the failed attempts?

It sounds like there’s simply not enough information to gauge if pharmaceutical companies are being honest about their claims of R&D costs.

replies(2): >>40175362 #>>40175598 #
2. lotsofpulp ◴[] No.40175362[source]
There is nothing stopping governments around the world from spending money to do their own R&D and conduct their clinical trials.
replies(1): >>40175954 #
3. kazinator ◴[] No.40175598[source]
If the government hands out grants, about which information is subsequently hard to get, that points to a gaping transparency issue squarely on the government side.

Pharma R&D companies that are publicly listed should have some information about their balance sheets.

Private equity ones are going to be the most opaque. That's kind of their prerogative.

4. rysertio ◴[] No.40175954[source]
They do. But then the patents gets leeched by big pharma companies investing a fraction of the development costs.
replies(1): >>40176213 #
5. lotsofpulp ◴[] No.40176213{3}[source]
Why does the government allow big pharma companies to “leech” the patent? What does that even mean? Can you describe the steps by which big pharma obtains the patent?